Physician profile
Scott Huber
NPI 1932139078
$1,237.62
in general payments reported to CMS, 2019-2025
19 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $88.65 · 2021: $130 · 2022: $213 · 2023: $291 · 2024: $204 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592 · Education: $30.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $591.55 |
| Education | $30.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $371.05 | 2020-2025 | |
| Janssen Biotech, INC. | $324.12 | 2020-2023 | Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $76.52 | 2021-2025 | Eohilia |
| Olympus America INC. | $65.25 | 2019-2020 | |
| Pfizer INC. | $53.27 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.41 | 2019-2025 | Xifaxan |
| Celgene Corporation | $37.94 | 2021-2024 | Zeposia |
| Lumendi LLC | $36.00 | 2019-2020 | |
| Ardelyx, INC. | $32.95 | 2022-2024 | Ibsrela |
| Qol Medical, LLC | $28.74 | 2019 | |
| Intercept Pharmaceuticals, INC. | $24.34 | 2023 | Ocaliva |
| Phathom Pharmaceuticals, INC. | $24.23 | 2024 | Voquezna |
| Boston Scientific Corporation | $22.38 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $21.01 | 2021 | |
| Nestle Healthcare Nutrition INC. | $16.85 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $15.22 | 2024 | Rybelsus, Ozempic |
| Eisai INC. | $15.02 | 2019 | |
| Dynavax Technologies Corporation | $12.78 | 2019 | |
| Braintree Laboratories, INC. | $11.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Huber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.